SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-012519 to MICROVISION, INC. (MVIS) (CIK 0000065770) (MVIS)

MICROVISION, INC. (MVIS) (CIK 0000065770)
Date: Nov. 12, 2024 · CIK: 0000065770 · Accession: 0000000000-24-012519

AI Filing Summary & Sentiment

File numbers found in text: 333-282840

Date
November 12, 2024
Author
Not clearly detected
Form
UPLOAD
Company
MICROVISION, INC. (MVIS) (CIK 0000065770)

Letter

November 12, 2024 Sumit Sharma Chief Executive Officer Microvision, Inc. 18390 NE 68th Street Redmond, WA 98052 Re:Microvision, Inc. Registration Statement on Form S-3 Filed on October 25, 2024 File No. 333-282840 Dear Sumit Sharma: We have reviewed your response and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our November 5, 2024 letter. Registration Statement on Form S-3 filed on October 25, 2024 General 1.We note your response to our prior comment 1. Please revise your disclosure to clearly state that the 42,692,019 shares being offered are those underlying notes in the aggregate principal amount of $45,000,000 that were issued to the selling stockholder on October 23, 2024. In this regard, we note that the capitalized term "Convertible Note" appears to be used interchangeably to refer to both the $45,000,000 principal amount that has been issued and the entire $75,000,000 principal amount that may be issued. Please further revise your disclosure to clarify that you expect to register any additional shares underlying notes in the aggregate principal amount of up to $30,000,000 that may be issued in the future to the selling stockholder, and discuss the potential dilution to investors.

November 12, 2024 Page 2 Please contact Sarah Sidwell at 202-551-4733 or Jennifer Angelini at 202-551-3047 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc:Thomas Fraser

Show Raw Text
November 12, 2024
Sumit Sharma
Chief Executive Officer
Microvision, Inc.
18390 NE 68th Street
Redmond, WA 98052
Re:Microvision, Inc.
Registration Statement on Form S-3
Filed on October 25, 2024
File No. 333-282840
Dear Sumit Sharma:
            We have reviewed your response and have the following comment.
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our November 5, 2024 letter.
Registration Statement on Form S-3 filed on October 25, 2024
General
1.We note your response to our prior comment 1. Please revise your disclosure to
clearly state that the 42,692,019 shares being offered are those underlying notes in the
aggregate principal amount of $45,000,000 that were issued to the selling stockholder
on October 23, 2024. In this regard, we note that the capitalized term "Convertible
Note" appears to be used interchangeably to refer to both the $45,000,000 principal
amount that has been issued and the entire $75,000,000 principal amount that may be
issued. Please further revise your disclosure to clarify that you expect to register any
additional shares underlying notes in the aggregate principal amount of up to
$30,000,000 that may be issued in the future to the selling stockholder, and discuss
the potential dilution to investors.

November 12, 2024
Page 2
            Please contact Sarah Sidwell at 202-551-4733 or Jennifer Angelini at 202-551-3047
with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:Thomas Fraser